Search research articles
Contact Us
Filters
Showing results (861-870 of 946) with videos related to
Page
of 95
Sort By:
Liver Cancer
|
March 27, 2025
Neratinib Alone or in Combination with Immune Checkpoint Inhibitors with or without Mammalian Target of Rapamycin Inhibitors in Patients with Fibrolamellar Carcinoma
Ghassan K Abou-Alfa, Tim Meyer, Richard Kinh Gian Do, et al.
Biorxiv : the Preprint Server for Biology
|
April 8, 2025
High-throughput protein target mapping enables accelerated bioactivity discovery for ToxCast and PFAS compounds
Diwen Yang, Xiaoyun Wang, Jiabao Liu, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine
|
June 2, 2022
High prevalence of fluoroquinolone-resistant UTI among US emergency department patients diagnosed with urinary tract infection, 2018-2020
Brett A Faine, Megan A Rech, Priyanka Vakkalanka, et al.
Radiology
|
February 2, 2018
In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of <sup>18</sup>F-(2S,4R)-4-Fluoroglutamine
Mark P S Dunphy, James J Harding, Sriram Venneti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2021
Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection
Joshua S Jolissaint, Kevin C Soares, Kenneth P Seier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2022
Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial
Funda Meric-Bernstam, Nizar M Tannir, Othon Iliopoulos, et al.
Annals of Surgical Oncology
|
October 9, 2023
Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma
Stijn Franssen, Jessica J Holster, Joshua S Jolissaint, et al.
JCO Precision Oncology
|
September 11, 2020
Real-World Outcomes of an Automated Physician Support System for Genome-Driven Oncology
Jessica J Tao, Michael H Eubank, Alison M Schram, et al.
The Oncologist
|
March 11, 2020
Phase II Multicenter, Open-Label Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma
Ghassan K Abou-Alfa, Robert Mayer, Alan P Venook, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 1, 2018
Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention
Maeve A Lowery, Ryan Ptashkin, Emmet Jordan, et al.
Page
of 95
Search research articles
Search
Showing results (861-870 of 946) with videos related to
Sort By:
Page
of 95
Liver Cancer
|
March 27, 2025
Neratinib Alone or in Combination with Immune Checkpoint Inhibitors with or without Mammalian Target of Rapamycin Inhibitors in Patients with Fibrolamellar Carcinoma
Ghassan K Abou-Alfa, Tim Meyer, Richard Kinh Gian Do, et al.
Biorxiv : the Preprint Server for Biology
|
April 8, 2025
High-throughput protein target mapping enables accelerated bioactivity discovery for ToxCast and PFAS compounds
Diwen Yang, Xiaoyun Wang, Jiabao Liu, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine
|
June 2, 2022
High prevalence of fluoroquinolone-resistant UTI among US emergency department patients diagnosed with urinary tract infection, 2018-2020
Brett A Faine, Megan A Rech, Priyanka Vakkalanka, et al.
Radiology
|
February 2, 2018
In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of <sup>18</sup>F-(2S,4R)-4-Fluoroglutamine
Mark P S Dunphy, James J Harding, Sriram Venneti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2021
Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection
Joshua S Jolissaint, Kevin C Soares, Kenneth P Seier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2022
Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial
Funda Meric-Bernstam, Nizar M Tannir, Othon Iliopoulos, et al.
Annals of Surgical Oncology
|
October 9, 2023
Gemcitabine with Cisplatin Versus Hepatic Arterial Infusion Pump Chemotherapy for Liver-Confined Unresectable Intrahepatic Cholangiocarcinoma
Stijn Franssen, Jessica J Holster, Joshua S Jolissaint, et al.
JCO Precision Oncology
|
September 11, 2020
Real-World Outcomes of an Automated Physician Support System for Genome-Driven Oncology
Jessica J Tao, Michael H Eubank, Alison M Schram, et al.
The Oncologist
|
March 11, 2020
Phase II Multicenter, Open-Label Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma
Ghassan K Abou-Alfa, Robert Mayer, Alan P Venook, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 1, 2018
Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention
Maeve A Lowery, Ryan Ptashkin, Emmet Jordan, et al.
Page
of 95